# A Study of the Safety of Atezolizumab in Patients With Advanced or Metastatic Urothelial Carcinoma in Argentina

> **NCT03330886** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 13 (actual)

## Conditions studied

- Urothelial Carcinoma

## Interventions

- **DRUG:** Atezolizumab

## Key facts

- **NCT ID:** NCT03330886
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-09
- **Primary completion:** 2019-03-02
- **Final completion:** 2019-03-02
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2023-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03330886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03330886, "A Study of the Safety of Atezolizumab in Patients With Advanced or Metastatic Urothelial Carcinoma in Argentina". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03330886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*